Skip to main content
. 2019 Mar 30;11(4):456. doi: 10.3390/cancers11040456
AMPK AMP-activated protein kinase
Apaf-1 protease activating factor-1
Apo2L Apo-2 ligand
ATG autophagy-related genes
Bak Bcl-2 antagonist or killer
Bax Bcl-2-associated X protein
Bcl-2 B-cell CLL/lymphoma 2
Bcl-xL B-cell lymphoma-extra-large
BH Bcl-2 homology
Bid BH3-only protein
BIR baculovirus IAP repeat
CLL chronic lymphocytic leukemia
CTC circulating tumour cells
c-FLIP cellular (FADD-like IL-1β-converting enzyme)-inhibitory protein
c-FLIPL c-FLIP large
c-FLIPS c-FLIP short
cIAP cellular inhibitor of apoptosis protein
CPT circularly permuted TRAIL
DcR decoy receptor
DD death domain
DED death effector domains
DISC death-inducing signalling complex
DLT dose-limiting toxicity
DR death receptor
ERK extracellular signal-regulated kinases
FADD Fas-associated death domain
FAP fibroblast-activation protein
Fc fragment crystallizable region
FDA United States Food and Drug Administration
FLICE FADD-like IL-1β-converting enzyme
FOLFIRI folinic acid, fluorouracil, irinotecan
GALNT14 polypeptide N-acetylgalactosaminyltransferase 14
GPI glycosylphosphatidylinositol
HCC hepatocellular carcinoma
HSA human serum albumin
HTS high-throughput screenings
IgG Immunoglobulin G
IKK inhibitor of κB kinase
IL interleukin
iz isoleucin
IκB inhibitor of κB
JNK c-Jun N-terminal kinases
KRAS Kirsten rat sarcoma
LUBAC linear ubiquitin chain assembly complex
LZ leucine zipper
MAPK mitogen-activated protein kinase
Mcl-1 myeloid leukaemia cell differentiation protein
miRNA microRNA
MOM mitochondrial outer membrane
MOMP mitochondrial outer membrane permeabilization
MPD membrane-proximal domain
MTD maximum tolerated dose
mTOR mechanistic target of rapamycin
NEMO NF-κB essential modifier
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells
NIAP neuronal apoptosis inhibitory protein
NSCLC non-small-cell lung cancer
OPG osteoprotegerin
ORR objective response rate
OS overall survival
PFS progression-free survival
pI isoelectric point
PI3K tyrosine kinase Src and phosphoinositide 3-kinase
PUMA p53 upregulated modulator of apoptosis
Rac1 Ras-related C3 botulinum toxin substrate 1
rhTRAIL recombinant human TRAIL
RIPK receptor-interacting protein kinase
RRMM relapsed refractory multiple myeloma
scTRAIL single-chain TRAIL
SMAC/DIABLO second mitochondrial activator of caspases/direct inhibitor of apoptosis-binding protein with low pI
SR superfamily
tBID truncated BH3-only protein
TD thalidomide/dexamethasone
TNF tumor necrosis factor
TNF-SF TNF-superfamily
TRAF2 TNF receptor-associated factor-2
TRAE treatment-related adverse events
TRAIL TNF-related apoptosis-inducing ligand
TRAIL-R TRAIL receptor
TRA TRAIL receptor agonist
Ts-IAP testis-specific IAP
USP8 ubiquitin-specific peptidase 8
VHH high-affinity heavy chain domain
XIAP X-linked inhibitor of apoptosis protein